Monographie - Metaraminol - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Simpaticomimetico

Metaraminol

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Metaraminol 0.5 mg/ml solution for injection	Gran Bretagna
Metaraminol 10 mg/ml solution for injection or infusion	Gran Bretagna

Bibliografia

Iniezione

Bibliografia : Metaraminol

	tipo	pubblicazione
552	Rivista	Martinez JF, Trissel LA, Gilbert DL. Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions. Int J Pharm Compound 1997 ; 1: 356-358.
1036	Rivista	Hasegawa GR, Eder JF. Visual compatibility of amiodarone hydrochloride injection with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 1379-1380.
1041	Rivista	Hasegawa GR, Eder JF. Visual compatibility of dobutamine hydrochloride with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 949-951.
1057	Rivista	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1201	Rivista	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
3758	Rivista	To T.P, Ching M.S, Booth J.C, Zeglinski P, McGrath A, Elli A.G,Garrett K. Feasibility and stability of metaraminol in pre-filled syringes. J Pharm Pract and Res 2014 ; 44, 89?94

Mentions Légales